View all newsletters
Receive our newsletter - data, insights and analysis delivered to you

Novo Nordisk Pharmatech to Attend World Vaccine Congress

Novo Nordisk Pharmatech has announced it will be returning for the annual World Vaccine Congress.

2017 will be the 17th year World Vaccine Congress has run. Held in Washington D.C. from 10 April until 12 April, Novo Nordisk Pharmatech will be present at booth #54.

The company would like to invite you to visit the booth and discover more about recombinant insulin for innovative biologics and pharmaceutical grade Quaternary ammonium compounds.

Novo Nordisk remains one of the best suppliers of insulin for cell culture processes through excellence at every step of the supply chain, and the company has more than 65 years’ experience in the biopharmaceutical and pharmaceutical industries.

Novo Nordisk delivers a proven record of product purity, reliability, and consistency, creating high-quality products for future therapies.

For more than 30 years, the National Research Council of Canada has been helping clients develop, optimise, scale-up and transfer bioprocesses to produce biologics and...
The Chinese hamster ovary (CHO) cell line is widely used for the production of recombinant proteins due to its high growth capacity and productivity, as...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology